🟢 Tscan Therapeutics is trading 6% up in pre-market with no fresh catalyst identified

Tscan Therapeutics is trading at $0.34, up 5.82%, with no new company-specific catalyst identified.

• No new Tscan Therapeutics announcement was identified for September 16, 2026; the latest major release was the September 2 strategic reorganization.
• The broader market is modestly higher, but index gains remain below the specified threshold; the advance has no confirmed explanation, and the earlier update is not a fresh catalyst.